MELISSA REDMOND: Open Payments
NPI 1093234866 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,460 in 177 payments from 22 companies in 2025. Trend: 2023 $2,785 · 2024 $2,647 · 2025 $3,460
Food & beverage: $3,460
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 34 | $753 |
| Abbott Laboratories | 28 | $552 |
| AstraZeneca Pharmaceuticals LP | 17 | $347 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $285 |
| Merck Sharp & Dohme LLC | 10 | $200 |
| CVRx, Inc. | 8 | $199 |
| PFIZER INC. | 12 | $194 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $178 |
| BridgeBio Pharma, Inc. | 6 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $150 |
Products named: ONPATTRO, CARDIOMEMS, Kerendia, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Barostim Neo System, VYNDAQEL, LifeVest, FARXIGA.
Industry payments across SC — which companies pay providers there.
